PDTM-12. ADGRB3 IS EPIGENETICALLY SILENCED IN...

Neuro-Oncology 2019 / 11 Vol. 21; Iss. Supplement

PDTM-12. ADGRB3 IS EPIGENETICALLY SILENCED IN WNT-MEDULLOBLASTOMA AND ITS REACTIVATION HAS THERAPEUTIC BENEFITS

Bhattacharya, Debanjan, Zhu, Dan, Osuka, Satoru, Kaluz, Stefan, Devi, Narra, Van Meir, Erwin
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/noz175.788
Date:
November, 2019
File:
PDF, 148 KB
2019
Conversion to is in progress
Conversion to is failed